In mouse models with ovarian cancer or colon cancer, combination of oncolytic vaccinia virus and anti-PD-L1 treatment lowered Tregs, exhausted CD8+ T cells, and PD-L1 expression in the TME, while increasing effector T cells [100]. This evidence concerns the gene CD274 and ovarian carcinoma.